Tag: Leukemia

Immune-Onc Therapeutics gets FDA orphan drug status for IO-202 in CMML

businessnewstoday- February 22, 2024

Immune-Onc Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapies in immunology and oncology, has achieved a significant milestone with the ... Read More

Zydus Lifesciences gains FDA approval for Cyclophosphamide Capsules

businessnewstoday- December 17, 2023

Zydus Lifesciences Limited, a leading pharmaceutical company, has achieved a significant milestone by receiving final approval from the United States Food and Drug Administration (USFDA) ... Read More

Lilly announces promising results for Pirtobrutinib Phase 1/2 trials

businessnewstoday- July 7, 2023

Eli Lilly's oncology arm, Loxo@Lilly, disclosed that The New England Journal of Medicine (NEJM) has published an extensive analysis of results from the BRUIN Phase ... Read More

Aurobindo subsidiary gets license to develop and market Nilotinib Capsules in LMICs

businessnewstoday- June 24, 2023

Aurobindo Pharma, along with its subsidiary Eugia Pharma Specialities has announced a voluntary sub-licensing agreement with Medicines Patent Pool (MPP) to develop and market Nilotinib ... Read More

BeiGene gets Brukinsa FDA approval for chronic lymphocytic leukemia

Raghuram Kadari- January 21, 2023

BeiGene has secured the approval of the US Food and Drug Administration (FDA) for the company’s Brukinsa (zanubrutinib) for the treatment of adult patients with ... Read More

Genentech bags Lunsumio FDA approval for R/R follicular lymphoma

Raghuram Kadari- December 28, 2022

Lunsumio FDA approval : Genentech, a subsidiary of the Roche Group, has secured the approval of the US Food and Drug Administration (FDA) for Lunsumio ... Read More

Rigel Pharmaceuticals gets Rezlidhia FDA approval for AML

Raghuram Kadari- December 6, 2022

Rigel Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its Rezlidhia (olutasidenib) capsules for relapsed or refractory (R/R) acute myeloid ... Read More

Alembic Pharmaceuticals gets FDA approval for Dasatinib Tablets

pallavi123- June 12, 2022

Alembic Pharmaceuticals has secured tentative approval for the abbreviated new drug application (ANDA) of Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 ... Read More

Aurobindo subsidiary Eugia gets FDA approval for Cyclophosphamide Injection

pallavi123- August 28, 2021

Aurobindo Pharma said that its subsidiary Eugia Pharma Specialities has secured approval from the US Food and Drug Administration (FDA) for the new drug application ... Read More

Jazz Pharmaceuticals gets Rylaze FDA approval for ALL and LBL

pallavi123- July 3, 2021

Rylaze FDA approval : Jazz Pharmaceuticals has secured approval for its leukemia drug Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn or JZP458) from the US Food and ... Read More